| Original language | American English |
|---|---|
| State | Published - Jun 1 2021 |
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
A Phase 1/2 Study of Selinexor in Combination with Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
Research output: Contribution to conference › Presentation